Clostridium butyricum ameliorates atherosclerotic inflammation through regulation of gut microbiota

Key Points

• Atherosclerotic inflammation decreased significantly with Clostridium butyricum intervention, supporting its therapeutic potential.
• The study indicated a notable reduction in inflammatory markers, with specific immune response shifts observed.
• Analysis involved assessing changes in gut microbiota profiles linked to atherosclerosis in various models.
• These findings highlight the importance of gut microbiota in managing cardiovascular inflammation, urging further exploration.